NCT06444035

Extended Therapeutic Effect of 35kDa Hyaluronan Fragment Injection in Patients With Chronic Pain Caused by Myofascial Pain Syndrome

35kDa Hyaluronan Fragment Injection Treatment Myofascial Pain Syndrome

• Status: Enrolling By Invitation
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: Nakhia Impex LLC · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

To verify the efficacy and safety of HA35 in chronic pain management and to further supplement effective treatments for chronic pain, we designed a proof-of-concept clinical study. This study aims to evaluate the 15-day treatment of HA35 on patients with myofascial pain syndrome and to observe the effects for up to 3 months.

Conditions

• Chronic Wound
• Myofascial Pain Syndrome

Interventions

Type	Name	Description
DRUG	HA35 injection	HA35/B-HA injection (Registration number L20200708MP07707; Ministry of Health). The subjects can continue to take oral analgesics during the treatment period, and the comparison of the dose and interval days of the analgesics before and after the treatment can also be used as the effect judgment of the injection.

Timeline

• Start date: 2024-05-30
• Primary completion: 2024-10-30
• Completion: 2024-12-01
• First posted: 2024-06-05
• Last updated: 2024-06-06

Locations

1 site across 1 country: Mongolia